Cargando…
Tunicamycin enhances the antitumor activity of trastuzumab on breast cancer in vitro and in vivo
Trastuzumab, a humanized monoclonal antibody targeting HER2, has demonstrated clinical benefits for women with HER2-positive breast cancer; however, trastuzumab resistance remains the biggest clinical challenge. In this study, results showed that tunicamycin, an inhibitor of N-glycosylation, synergi...
Autores principales: | Han, Xiqian, Zhang, Xiaobing, Li, Hui, Huang, Shengshi, Zhang, Shu, Wang, Fengshan, Shi, Yikang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770746/ https://www.ncbi.nlm.nih.gov/pubmed/26498681 |
Ejemplares similares
-
Curdlan sulfate–O-linked quaternized chitosan nanoparticles: potential adjuvants to improve the immunogenicity of exogenous antigens via intranasal vaccination
por: Zhang, Shu, et al.
Publicado: (2018) -
Microbubbles Enhance the Antitumor Effects of Sinoporphyrin Sodium Mediated Sonodynamic Therapy both In Vitro and In Vivo
por: Wang, Haiping, et al.
Publicado: (2015) -
Involvement of Orai1 in tunicamycin-induced endothelial dysfunction
por: Yang, Hui, et al.
Publicado: (2019) -
Localized co-delivery of collagenase and trastuzumab by thermosensitive hydrogels for enhanced antitumor efficacy in human breast xenograft
por: Pan, Anni, et al.
Publicado: (2018) -
Analysis of the Tunicamycin Biosynthetic Gene Cluster of Streptomyces chartreusis Reveals New Insights into Tunicamycin Production and Immunity
por: Widdick, David, et al.
Publicado: (2018)